NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding NRX Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 34 | 30 | −4 |
| Shares | 3.71M | 3.99M | +277.2K (+7.5%) |
| Value | $964.7K | $1.84M | +$873.1K (+90.5%) |
New holders (4)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AdvisorShares Investments LLC | 642,632 | $295.6K | 0.07% |
| One Wealth Management Investment & Advisory Services, LLC | 140,402 | $64.6K | 0.03% |
| HighPoint Advisor Group LLC | 43,501 | $23.0K | 0.00% |
| Bank of America Corp | 72 | $34 | 0.00% |
Sold out (8)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Sabby Management, LLC | 325,000 | $84.5K |
| Millennium Management LLC | 157,182 | $40.9K |
| Two Sigma Securities, LLC | 53,250 | $13.8K |
| Susquehanna International Group, LLP | 14,099 | $3.67K |
| Lido Advisors, LLC | 13,000 | $3.38K |
| XTX Topco Ltd | 11,809 | $3.07K |
| Wolverine Asset Management LLC | 9,644 | $2.51K |
| Hibernia Wealth Partners, LLC | 250 | $65 |